262 related articles for article (PubMed ID: 29849496)
1. Serotonin Exhibits Accelerated Bleomycin-Induced Pulmonary Fibrosis through TPH1 Knockout Mouse Experiments.
Zhang J; Cui R; Feng Y; Gao W; Bi J; Li Z; Liu C
Mediators Inflamm; 2018; 2018():7967868. PubMed ID: 29849496
[TBL] [Abstract][Full Text] [Related]
2. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
[TBL] [Abstract][Full Text] [Related]
3. Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice.
Cai Y; Kimura S
PLoS One; 2015; 10(11):e0142497. PubMed ID: 26559674
[TBL] [Abstract][Full Text] [Related]
4. Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: Decisive role of Bax, Nrf2, NF-κB, Muc5ac, TNF-α and IL-1β.
Kandhare AD; Bodhankar SL; Mohan V; Thakurdesai PA
Chem Biol Interact; 2015 Jul; 237():151-65. PubMed ID: 26093215
[TBL] [Abstract][Full Text] [Related]
5. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
Yasui H; Gabazza EC; Tamaki S; Kobayashi T; Hataji O; Yuda H; Shimizu S; Suzuki K; Adachi Y; Taguchi O
Am J Respir Crit Care Med; 2001 Jun; 163(7):1660-8. PubMed ID: 11401891
[TBL] [Abstract][Full Text] [Related]
6. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
7. [Effect of signal transducer and activator of transcription 1 antisense oligodeoxynucleotides on inflammatory mediators, type I and type III collagen mRNA of rat pulmonary fibrosis].
Wang WJ; Zeng M; Liu D; Fan XM; Zhu C; Zhan XQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 May; 25(5):389-92. PubMed ID: 19426591
[TBL] [Abstract][Full Text] [Related]
8. Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathway.
Liu L; Lu W; Ma Z; Li Z
Int J Mol Med; 2012 May; 29(5):815-22. PubMed ID: 22367596
[TBL] [Abstract][Full Text] [Related]
9. Rac2 is involved in bleomycin-induced lung inflammation leading to pulmonary fibrosis.
Arizmendi N; Puttagunta L; Chung KL; Davidson C; Rey-Parra J; Chao DV; Thebaud B; Lacy P; Vliagoftis H
Respir Res; 2014 Jun; 15(1):71. PubMed ID: 24970330
[TBL] [Abstract][Full Text] [Related]
10. Epicatechin protective effects on bleomycin-induced pulmonary oxidative stress and fibrosis in mice.
Shariati S; Kalantar H; Pashmforoosh M; Mansouri E; Khodayar MJ
Biomed Pharmacother; 2019 Jun; 114():108776. PubMed ID: 30903918
[TBL] [Abstract][Full Text] [Related]
11. Terrestrosin D from
Qiu M; An M; Bian M; Yu S; Liu C; Liu Q
Pharm Biol; 2019 Dec; 57(1):694-700. PubMed ID: 31608748
[No Abstract] [Full Text] [Related]
12. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
[TBL] [Abstract][Full Text] [Related]
13. C-type natriuretic peptide attenuates bleomycin-induced pulmonary fibrosis in mice.
Murakami S; Nagaya N; Itoh T; Fujii T; Iwase T; Hamada K; Kimura H; Kangawa K
Am J Physiol Lung Cell Mol Physiol; 2004 Dec; 287(6):L1172-7. PubMed ID: 15285999
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary fibrosis model of mice induced by different administration methods of bleomycin.
Gul A; Yang F; Xie C; Du W; Mohammadtursun N; Wang B; Le J; Dong J
BMC Pulm Med; 2023 Mar; 23(1):91. PubMed ID: 36944966
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G
Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714
[TBL] [Abstract][Full Text] [Related]
16. The exacerbating roles of CCAAT/enhancer-binding protein homologous protein (CHOP) in the development of bleomycin-induced pulmonary fibrosis and the preventive effects of tauroursodeoxycholic acid (TUDCA) against pulmonary fibrosis in mice.
Tanaka Y; Ishitsuka Y; Hayasaka M; Yamada Y; Miyata K; Endo M; Kondo Y; Moriuchi H; Irikura M; Tanaka K; Mizushima T; Oike Y; Irie T
Pharmacol Res; 2015 Sep; 99():52-62. PubMed ID: 26005208
[TBL] [Abstract][Full Text] [Related]
17. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
[TBL] [Abstract][Full Text] [Related]
18. Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice.
Ortiz LA; Lasky J; Hamilton RF; Holian A; Hoyle GW; Banks W; Peschon JJ; Brody AR; Lungarella G; Friedman M
Exp Lung Res; 1998; 24(6):721-43. PubMed ID: 9839161
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of compound Chuanxiong Kangxian granules on bleomycin-induced pulmonary fibrosis in rats.
Shi W; Feng B; Xu S; Shen X; Zhang T
Biomed Pharmacother; 2017 Dec; 96():1179-1185. PubMed ID: 29239818
[TBL] [Abstract][Full Text] [Related]
20. Bleomycin-induced pulmonary fibrosis is independent of eosinophils.
Hao H; Cohen DA; Jennings CD; Bryson JS; Kaplan AM
J Leukoc Biol; 2000 Oct; 68(4):515-21. PubMed ID: 11037973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
